Triple-Hormone-Receptor Agonist Retatrutide for Obesity. Reply.
Jastreboff A, Kaplan L, Hartman M. Triple-Hormone-Receptor Agonist Retatrutide for Obesity. Reply. New England Journal Of Medicine 2023, 389: 1629-1630. PMID: 37888927, DOI: 10.1056/nejmc2310645.Peer-Reviewed Original Research